Skip to content

Ethanol Gen.2 08057630190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336121221), received between Jul 20, 2023 and Feb 5, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “High Test Results” (1 report).

7 other recalls cover devices cleared under the same FDA submission (K951595); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results1
  • Non Reproducible Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 5, 2026Non Reproducible Results

    THE INITIAL REPORTER STATED THEY RECEIVE QUESTIONABLE RESULTS FOR AN UNSPECIFIED NUMBER OF PATIENT SAMPLES TESTED WITH ETHANOL GEN.2 ON A COBAS C 503 ANALYTICAL UNIT. THE CUSTOMER STATED THAT THE QUESTIONED RESULTS ARE FROM PATIENTS WHO HAS PHYSICAL SYMPTOMS OF ALCOHOL INTOXICATION. QUALITATIVE BREATH ALCOHOL CONCENTRATION (BREATHALYZER) MEASUREMENTS OF THESE PATIENTS ARE POSITIVE. ONE HOUR AFTER THE BREATHALYZER MEASUREMENTS, SAMPLES ARE COLLECTED FROM THESE PATIENTS AND HAVE ETHANOL RESULTS FROM THE C 503 ANALYZER THAT ARE BELOW THE MEASURING RANGE OF THE ASSAY. THE CUSTOMER PROVIDED SPECIFIC EXAMPLES FOR TWO PATIENTS. ON 08-MAR-2025, THE FIRST PATIENT WAS OBSERVED TO BE APPARENTLY INTOXICATED. THE FACILITY ADMINISTERED BREATHALYZER TESTING WITH A CDP7000 BREATHALYZER AND THE RESULT WAS 62 MG/100 ML OF ALCOHOL. FIVE MINUTES LATER, THE BREATHALYZER WAS REPEATED AND THE RESULT WAS 44 MG/100 ML OF ALCOHOL. A VENOUS SAMPLE WAS COLLECTED FROM THE PATIENT AND MEASURED ON THE C 503 SYSTEM, RESULTING IN AN ETHANOL VALUE OF < 10 MG/DL. ON (B)(6) 2025, THE SECOND PATIENT WAS OBSERVED TO BE APPARENTLY INTOXICATED. THE FACILITY ADMINISTERED BREATHALYZER TESTING WITH A CDP7000 BREATHALYZER AN

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24270727 ↗
  • MalfunctionJul 20, 2023High Test Results; High Test Results

    WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT'S SERUM SAMPLE TESTED WITH ETHANOL GEN.2 (ETOH2) ASSAY ON A COBAS PRO C 503 ANALYZER. INITIAL RESULT: 137 MG/DL. THE PHYSICIAN QUESTIONED THE RESULT AND THE PATIENT DENIED USING ALCOHOL. THE SAMPLE WAS RERUN. RERUN RESULT: 0 MG/DL THE RERUN RESULT DEEMED TO BE CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17363018 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K951595. One submission often covers many models, so check the product and lot details in each record.

  • Z-1675-2021 · Apr 26, 2021 · Open, Classified
    IRON GEN 2: ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES, Catalog#: 03183696122 - Product Usage: In vitro test for the quantitative determination of iron in human serum and plas
  • Z-0100-2017 · Jul 15, 2016 · Terminated
    Roche COBAS INTEGRA 800 /800 CTS Analyzer Analyzer, Chemistry (Photometric, Discrete for Clinical use Product Usage: The system cobas p612 is a computer-controlled stand-alone sys
  • Z-0168-2014 · Sep 16, 2013 · Terminated
    COBAS INTEGRA 800 Analyzer with software 9864.C2 Cobas. COBAS Part Numbers 28122474001, 28122474692, 04559126001, 04589459970 corresponding to the Analyzer with or without closed
  • Z-0696-2013 · Nov 19, 2012 · Terminated
    Roche COBAS INTEGRA 400 and 400 plus Analyzer, an in vitro diagnostic analyzer.
  • Z-0007-2009 · Jun 11, 2008 · Terminated
    Roche Diagnostics IRON2, Iron Gen. 2, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 03183696122. An in-vitro diagnostic reagent system intended for use on
  • Z-0012-2009 · Jun 11, 2008 · Terminated
    Roche Diagnostics NAPA2, N-Acetyl-Procainamide, COBAS INTEGRA, Roche Diagnostics, Indianapolis, IN.; 20737852322. An in-vitro diagnostic reagent system intended for use on COBAS I
  • Z-0667-03 · Feb 13, 2003 · Terminated
    COBAS INTEGRA Creatinine Jaffe for use on the INTEGRA 400, 700 and 800 analyzers; system ID # 0764345, catalog # 20764345

Other ALCOHOL DEHYDROGENASE, SPECIFIC REAGENT FOR ETHANOL ENZYME METHOD devices

All ALCOHOL DEHYDROGENASE, SPECIFIC REAGENT FOR ETHANOL ENZYME METHOD devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.